MS Contin rectal cancer pain control in patients with advanced gastrointestinal cancer clinical observation of.docVIP

 PAGE \* MERGEFORMAT 6 MS Contin rectal cancer pain control in patients with advanced gastrointestinal cancer clinical observation of Author: Jiang New Yueluo Lin Cheng You-Zhong Zhang Jin Zhang Hui tangjiang if [Abstract] Objective: Observing the curative effect of MST rectally according to advanced stage digestive tract tumorpatients cancer ache.Methods: 48 cases with intractable nausea vomiting and dysphagia moderate or severe ache patients, injection meperidine for muscle 3 days, and then change to use MST rectally.Results: Total effective rate is 100%. Effectual rate is 93.6%. Side effect is the main with constipation nausea, vomiting, hallucination, there is on any relation.Conclusion: MST rectally has good analgesia effect, and on wounded, safe, easy.It ‘s fit to digestive tract tumor patients cancer with no oral, it’s a kind of method to control ache. [Keywords:] MST rectally cancer ache curative effect The incidence of advanced cancer pain as high as 70%, and with advanced gastrointestinal tumors with intestinal obstruction or refractory nausea, vomiting, difficulty in swallowing for patients, often caused by failure of oral administration. In our hospital since 1998, using MS Contin (morphine sulfate controlled-release tablets, MST) rectal treatment of moderate and severe cancer pain, 48 cases achieved good efficacy, these are as follows. A clinical data 1.1 General information on this group a total of 48 cases, of which 32 cases of male, female, 16 patients aged 42 -81 years of age. All the cases were confirmed by clinical and pathological tests for advanced gastrointestinal tumors. Primary tumor were as follows: 20 cases of gastric cancer (41.7%), esophageal cancer, 12 cases (25%), colon, rectal cancer, 8 cases (16.7%), liver in 4 cases (8.3%), pancreatic cancer, 4 cases (8.3 %). Types of pain: visceral pain in 26 cases (54.2%), soft tissue pain in 12 cases (25%), bone pain and 6 cases (12.5%), neuralgia, 4 cases (8.3%). Pain location: abdomin